Determination of the combination of GDF-15, IL-6, LCN-2, and TIM-3 markers can indeed complement coronary angiography in the diagnosis, risk assessment, and management of coronary artery disease (CAD). This evidence concerns the gene IL6 and coronary artery disorder.